Clinical Trials in Nashville

Showing 2701-2720 of 9,711 trials

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

NCT01968187

The purpose of this study is to evaluate the safety and effectiveness of intranasal FE 992097 in children and adults with Prader-Willi Syndrome.

Hyperphagia in Prader-Willi Syndrome

Ferring Pharmaceuticals38 participantsStarted Jan 2014

Gainesville, Florida, United States • Mineola, New York, United States • Nashville, Tennessee, United States

COMPLETEDNA< 1 mile

MIP Versus PCNL for Kidney Stone Disease

NCT04767919

The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

Kidney Stone

University of California, San Diego75 participantsStarted Jan 2021

Phoenix, Arizona, United States • San Diego, California, United States • Cleveland, Ohio, United States +3 more locations

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

MIP Versus PCNL for Kidney Stone Disease

Find Trials by Condition in Nashville

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

A Prospective Observational Study of TPIAT

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Outcomes of a Skill-Based Program for Eating Disorders

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects